Warsaw gains ever greater tourist recognition

WARSAW, Poland, Oct. 23, 2023 /PRNewswire/ -- When Warsaw won the European Best Destination 2023 competition in February this year, interest in...

U.S. stocks are muted as the 10-year Treasury yield shoots above 5%

This article first appeared in Investing.com

Waterdrop Will Expand Global Reach At Aquatech Amsterdam Exhibition...

AMSTERDAM, Oct. 23, 2023 /PRNewswire/ -- Waterdrop, a prominent player in the water treatment and purification sector, is set to make waves at the pre...

LBB Specialties Announces Principal Partnership with Viscofan

NORWALK, Conn., Oct. 23, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredients distribution in Nort...

Shaw’s Chosen Among the Sponsors of Mass Save’s New Cohort of Climat...

Originally posted on Progressive Grocer.Shaw’s Supermarkets was named one of the Sponsors of Mass Save’s latest Mass Save Climate Leaders. The designa...

Extending diabetic eye screening to two years could risk sight loss,...

Researchers said ‘the incentive of biennial screening is to release capacity in the NHS’ and ‘lessen the inconvenience’ for diabetics at low risk.

Shamima Begum’s legal fight reaches Court of Appeal

The 24-year-old previously lost a challenge against the decision to strip her of her British citizenship on national security grounds.

XINGIMAGING and MITRO BIOTECH CO., LTD. MERGE TO DELIVER FULL-SERVIC...

NEW HAVEN, Conn., Oct. 23, 2023 /PRNewswire/ -- XINGIMAGING, LLC, and MITRO Biotech Co., Ltd., two recognized lead companies offering quality and exce...

Decode Global Introduces the Brand-new All-in-One Trading Platform:...

SINGAPORE, Oct. 23, 2023 /PRNewswire/ -- Decode Global, a top-tier global financial services group based in Sydney, Australia, is excited to announce...

VolunteerMatch and Crisis Text Line Partner To Highlight the Long-Te...

October 23, 2023 /3BL/ - VolunteerMatch, a nonprofit that provides a national digital infrastructure to serve volunteers and Crisis Text Line, a natio...

Genesis MedTech initiates enrolment in its North American Early Feas...

BURLINGAME, Calif., Oct. 23, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced initiation of enrolment in i...

BingX Unveils Fee Adjustments and Enhanced VIP Program

SINGAPORE, Oct. 23, 2023 /PRNewswire/ -- BingX, a leading global cryptocurrency exchange, is excited to announce a major enhancement to it...

2022 .gay Impact Report | Introducing GoDaddy Registry

As originally published in the 2022 .gay Impact ReportIntroducing GoDaddy Registry“GoDaddy’s offering of .gay domains empowers the LGBTQIA+ community...

HARMAN Audio Talks Podcast: AI Ate My IP

Evolution, revolution or the downfall of the music industry?In this episode of the AudioTalks podcast we speak to two AI visionaries about the impact...

U.S. stocks were falling as the 10-year Treasury yield shoots above...

This article first appeared in Investing.com

Viatris 2022 Sustainability Report: Water and Waste

Communities, patients and the manufacturing and application of pharmaceuticals all depend on the availability of clean, unpolluted water. Guided by ou...

Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Pl...

Latest data reveals a 55% confirmed response rate, median duration of response (DoR) and median progression-free survival (PFS) of more than 12 months...

ZE PowerGroup Secures Coveted Spot on the Chartis RiskTech100 and Cl...

ZE Data We Get It Chartis RiskTech100 Chartis_2024_Risk Data Aggregation and Reporting Award ZE PowerGroup secures 75th place on Chartis RiskTech100 a...

Verizon and Discovery Education Present New Virtual Field Trip Explo...

CHARLOTTE, N.C., October 23, 2023 /3BL/ - Discovery Education and Verizon today announced a new virtual experience – Bridge to the Future: A Virtual F...

Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for...

MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for...